Olema Pharmaceuticals, Inc. (OLMA) has 20 bekannte Insider- und institutionelle Anteilseigner verzeichnet. Der größte Anteilseigner ist Bain Capital Life Sciences Investors, LLC mit 7,500,000 Aktien. Weitere bedeutende Anteilseigner sind LAMPERT MARK N und Paradigm Biocapital Advisors LP.
In den letzten 12 Monaten haben Insider 40 Transaktionen in OLMA Aktien getätigt — 15 Käufe (im Wert von $14.93M) und 13 Verkäufe (im Wert von $10.04M). Insider-Käufe haben die Verkäufe übertroffen, was auf Vertrauen in die Unternehmensaussichten hindeuten kann.
OLMA Insider-Beteiligungen
Größter Aktionär
Bain Capital Life Sciences Investors, LLC
7,500,000 Aktien
Käufe (12 Monate)
15
$14.93M Wert
Verkäufe (12 Monate)
13
$10.04M Wert
12-Monats-Transaktionsaktivität
Top-Insider-Aktionäre
| # |
Name |
Funktion |
Gehaltene Aktien |
Zuletzt gemeldet |
Relative Größe |
| 1 |
Bain Capital Life Sciences Investors, Llc |
10 Percent Owner |
7,500,000 |
2025-01-13 |
|
| 2 |
Lampert Mark N |
Director |
2,906,659 |
2022-06-14 |
|
| 3 |
Paradigm Biocapital Advisors Lp |
10 Percent Owner |
783,118 |
2024-08-05 |
|
| 4 |
Harmon Cyrus |
Director |
727,770 |
2026-01-21 |
|
| 5 |
Bohen Sean |
President and CEO |
275,000 |
2026-02-04 |
|
| 6 |
Kovacs Shane William Charles |
Ch. Operating & Financial Off. |
239,727 |
2026-01-15 |
|
| 7 |
Moriarty John B |
EVP, Ch. Legal Officer & Sec. |
150,000 |
2023-02-02 |
|
| 8 |
Horn Kinney |
Chief Business Officer |
150,000 |
2023-02-02 |
|
| 9 |
Zojwalla Naseem |
Chief Medical Officer |
106,250 |
2026-02-04 |
|
| 10 |
Myles David C. |
Ch. Discov. & Non-clin Dev Off |
106,250 |
2026-02-04 |
|
| 11 |
Kushner Peter J. |
Officer |
61,750 |
2022-02-03 |
|
| 12 |
Mccormick Frank |
Director |
56,964 |
2020-11-19 |
|
| 13 |
Mitchell Shawnte |
Chief Legal Officer |
56,250 |
2026-02-04 |
|
| 14 |
Garland J. Scott |
Director |
24,150 |
2025-06-13 |
|
| 15 |
Butitta Cynthia M |
Director |
24,150 |
2025-06-13 |
|
| 16 |
Hrustanovic Gorjan |
Director |
24,150 |
2025-06-13 |
|
| 17 |
Clark Ian T |
Director |
24,150 |
2025-06-13 |
|
| 18 |
Rappaport Andrew |
Director |
24,150 |
2025-06-13 |
|
| 19 |
Horning Sandra |
Director |
24,150 |
2025-06-13 |
|
| 20 |
Graham G. Walmsley |
Director |
24,150 |
2025-06-13 |
|
Aktuelle Transaktionen (letzte 12 Monate)
| Datum |
Name |
Funktion |
Typ |
Aktien |
Kurs |
Wert |
| 2026-03-04 |
Mitchell Shawnte |
Chief Legal Officer |
Informierter Verkauf |
233 |
$24.69 |
$5.75K |
| 2026-03-03 |
Mitchell Shawnte |
Chief Legal Officer |
Informierter Verkauf |
15,000 |
$23.01 |
$345.15K |
| 2026-02-02 |
Austin Sasha Lu |
VP of Finance and Controller |
RSU-Zuteilung |
11,700 |
- |
- |
| 2026-02-01 |
Austin Sasha Lu |
VP of Finance and Controller |
Unbekannt |
13,000 |
$2.44 |
$31.72K |
| 2026-01-30 |
Austin Sasha Lu |
VP of Finance and Controller |
Unbekannt |
45,000 |
$4.37 |
$196.65K |
| 2026-02-02 |
Zojwalla Naseem |
Chief Medical Officer |
RSU-Zuteilung |
106,250 |
$25.65 |
$2.73M |
| 2026-02-02 |
Bohen Sean |
President and CEO |
RSU-Zuteilung |
275,000 |
$25.65 |
$7.05M |
| 2026-02-02 |
Myles David C. |
Ch. Discov. & Non-clin Dev Off |
RSU-Zuteilung |
106,250 |
$25.65 |
$2.73M |
| 2026-02-02 |
Mitchell Shawnte |
Chief Legal Officer |
RSU-Zuteilung |
56,250 |
$25.65 |
$1.44M |
| 2026-01-20 |
Harmon Cyrus |
Director |
Informierter Verkauf |
10,000 |
$26.88 |
$268.8K |
| 2026-01-14 |
Harmon Cyrus |
Director |
Informierter Verkauf |
3,489 |
$29.12 |
$101.6K |
| 2026-01-15 |
Kovacs Shane William Charles |
Ch. Operating & Financial Off. |
Informierter Verkauf |
100,000 |
$28.73 |
$2.87M |
| 2026-01-13 |
Kovacs Shane William Charles |
Ch. Operating & Financial Off. |
Informierter Verkauf |
3,822 |
$28.01 |
$107.05K |
| 2026-01-14 |
Myles David C. |
Ch. Discov. & Non-clin Dev Off |
Optionsausübung (Verkauf) |
50,000 |
$4.87 |
$243.5K |
| 2026-01-13 |
Myles David C. |
Ch. Discov. & Non-clin Dev Off |
Optionsausübung (Verkauf) |
50,000 |
$4.87 |
$243.5K |
| 2026-01-12 |
Myles David C. |
Ch. Discov. & Non-clin Dev Off |
Informierter Verkauf |
10,000 |
$28.34 |
$283.4K |
| 2025-12-26 |
Bohen Sean |
President and CEO |
Schenkung (gegeben) |
8,500 |
- |
- |
| 2025-12-22 |
Harmon Cyrus |
Director |
Informierter Verkauf |
2,881 |
$28.53 |
$82.19K |
| 2025-12-23 |
Zojwalla Naseem |
Chief Medical Officer |
Informierter Verkauf |
99,509 |
$27.66 |
$2.75M |
| 2025-12-22 |
Zojwalla Naseem |
Chief Medical Officer |
Informierter Verkauf |
100,000 |
$28.04 |
$2.8M |
| 2025-12-19 |
Zojwalla Naseem |
Chief Medical Officer |
Informierter Verkauf |
12,921 |
$28.93 |
$373.8K |
| 2025-12-19 |
Myles David C. |
Ch. Discov. & Non-clin Dev Off |
Schenkung (gegeben) |
9,000 |
- |
- |
| 2025-12-19 |
Clark Ian T |
Director |
Optionsausübung (Verkauf) |
21,520 |
$3.61 |
$77.69K |
| 2025-12-08 |
Kovacs Shane William Charles |
Ch. Operating & Financial Off. |
Schenkung (gegeben) |
75,000 |
- |
- |
| 2025-11-26 |
Kovacs Shane William Charles |
Ch. Operating & Financial Off. |
Schenkung (gegeben) |
225,000 |
- |
- |
